Miami: Women Rock at Human Amyloid Imaging Meeting Miami: Amyloid in the Aging Brain—What Does It Mean? Miami: Multimodal Imaging, New Way to Test Amyloid Hypothesis Miami: Astrocytes, Antidepressants, Microbleeds, and More Miami: Updates on J-ADNI, 18F ...
News Focus: 2012 Human Amyloid Imaging Conference Miami: Amyloid PET in the Clinic: What Are the Issues? Miami: Scan and Tell? Amyloid Imaging Confronts Disclosure Dilemma Miami: Can the Naked Eye Tell When a Scan Is Positive? Miami: When Does Amyloid ...
Solanezumab Selected for Alzheimer’s A4 Prevention Trial HAI—Spotlight on Tau Tracers at Human Amyloid Imaging Meeting HAI—Amyloid Imaging in the Clinic: New Guidelines and Data HAI—Sharper Curves: Revamping a Biomarker Staging Model HAI—Standardizing ...
Boston: Clinical Trial Results for Dimebon Unveiled Boston: Resting State MRI Shows Loss of Network Connectivity Early in AD American Academy of Neurology: 2007 Annual Meeting ...
Researchers Revel in C9ORF72 Advances at RNA Symposium Profilin-1 Links Cytoskeleton and RNA Aggregation in ALS The Four Stages of TDP-43 Proteinopathy Blocking a MicroRNA Slows Motor Neuron Disease in Mice Glial Cells Refine Neural Circuits Innate Immune ...
A Conference Devoted to Better Engaging Clinical Trial Volunteers Turning to the Internet for Alzheimer’s Trial Volunteers Patient Engagement in Clinical Trials ...
Cloistered Retreat Takes the Pulse of BACE Research BACE—Substrates, Functions, Developmental Phenotypes Blocking BACE—Do Adult Mouse Phenotypes Predict Side Effects? Meeting Explores Complex Biology of BACE Regulation BACE Proteases in Health and Disease ...
Combination Trial Debate Energizes Keystone Symposium Protecting Neurons by Ramping Up Waste Disposal? Prodromal Initiative to Identify Biomarkers for Parkinson’s Researchers Build on GWAS to Parse Genetic Players in AD and PD More than 200 researchers ...
Copper Mountain: Can CREB Save Memory? Copper Mountain: Knight Vision—SIRT1 Aids ADAM10, Slays Aβ Copper Mountain Brief: Rat-a-tat—New Model Comes a Knockin’ Copper Mountain: Death and Trophin Receptors—New Insight, New Drugs? Copper Mountain: Fractious ...
Keystone: γ Slowly Relinquishes Its Secrets Keystone: Lipids Grease γ-Secretase Activity Keystone: Loss Versus Gain—Mutations a Drag on γ-Secretase Fiendishly complicated, γ-secretase has proved a formidable foe to the structurally minded scientist. But ...
Zuers—Meeting Mixes Translational News and Debate Zuers—Αlpha, Beta, Sigma: Which Will Yield New AD Drug? Zuers—No Pill or Drip: Scientists Inject Phage Drug Into CSF Zuers—Can Spatial Navigation Guide Clinical Trials? The town of Zuers in the Austrian ...
St. Louis: ApoE Receptors—Hold Sway Over Synaptic Function St. Louis: ApoE—Receptors, Theories and Therapies St. Louis: ApoE—A Clearer View of its Role In AD? The apolipoprotein E gene is the strongest genetic risk factor for late-onset Alzheimer disease. ...
Therapeutic Approaches Target Deubiquitinase, Protein Turnover Paracrine Signal From BACE1-Clipped Neuregulin Rescues Myelin Could Longevity Factor, Epilepsy Med, Treat AD One Day? The small scientific workshop From Science to Therapeutics: The Best Way ...
Keystone: Symposium Emphasizes Key Aspects of ApoE Biology Keystone: Probing the Function of Lipoprotein and Related Receptors Keystone: ApoE Receptors and Ligands in Memory and AD Keystone: Does ApoE Fragmentation Drive Pathology? Keystone: Therapies ...